Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
UBS
Fish and Richardson
Daiichi Sankyo
Deloitte
Novartis
Accenture
Covington
Chubb
US Army

Generated: February 19, 2018

DrugPatentWatch Database Preview

Genzyme Corp Company Profile

« Back to Dashboard

Summary for Genzyme Corp
International Patents:112
US Patents:5
Tradenames:4
Ingredients:4
NDAs:5
Drug Master File Entries: 5

Drugs and US Patents for Genzyme Corp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Genzyme Corp FLUDARA fludarabine phosphate INJECTABLE;INJECTION 020038-001 Apr 18, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up
Genzyme Corp CAPRELSA vandetanib TABLET;ORAL 022405-001 Apr 6, 2011 RX Yes No 8,067,427 ➤ Sign Up Y ➤ Sign Up
Genzyme Corp CERDELGA eliglustat tartrate CAPSULE;ORAL 205494-001 Aug 19, 2014 RX Yes Yes 7,196,205 ➤ Sign Up Y ➤ Sign Up
Genzyme Corp CAPRELSA vandetanib TABLET;ORAL 022405-002 Apr 6, 2011 RX Yes Yes RE42353 ➤ Sign Up Y Y ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-002 Apr 6, 2000 AP RX Yes No ➤ Sign Up ➤ Sign Up
Genzyme Corp CERDELGA eliglustat tartrate CAPSULE;ORAL 205494-001 Aug 19, 2014 RX Yes Yes 6,916,802 ➤ Sign Up ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-001 Apr 6, 2000 AP RX Yes Yes ➤ Sign Up ➤ Sign Up
Genzyme Corp CAPRELSA vandetanib TABLET;ORAL 022405-001 Apr 6, 2011 RX Yes No ➤ Sign Up ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-003 Jul 13, 2009 AB RX Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Genzyme Corp

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-002 Apr 23, 2004 5,602,116 ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 5,602,116 ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-002 Apr 6, 2000 5,602,116 ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 5,707,980 ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 5,869,473 ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-001 Apr 6, 2000 5,602,116 ➤ Sign Up
Genzyme Corp FLUDARA fludarabine phosphate INJECTABLE;INJECTION 020038-001 Apr 18, 1991 4,357,324*PED ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 5,861,386 ➤ Sign Up
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-002 Apr 23, 2004 5,869,473 ➤ Sign Up
Genzyme Corp CAPRELSA vandetanib TABLET;ORAL 022405-001 Apr 6, 2011 6,414,148 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for GENZYME CORP drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 2 mcg/mL, 1 mL in 2 mL vial ➤ Subscribe 12/28/2011
➤ Subscribe Capsules 1 mcg ➤ Subscribe 2/12/2010
➤ Subscribe Capsules 0.5 mcg and 2.5 mcg ➤ Subscribe 3/25/2009
➤ Subscribe Injection 2 mcg/mL, 2 mL ampules ➤ Subscribe 10/15/2007

Non-Orange Book US Patents for Genzyme Corp

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,138,353 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors ➤ Sign Up
5,916,911 Amino ceramide--like compounds and therapeutic methods of use ➤ Sign Up
6,030,995 Amino ceramide-like compounds and therapeutic methods of use ➤ Sign Up
6,890,949 Amino ceramide-like compounds and therapeutic methods of use ➤ Sign Up
7,763,738 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors ➤ Sign Up
6,040,332 Amino ceramide-like compounds and therapeutic methods of use ➤ Sign Up
6,255,336 Amino ceramide-like compounds and therapeutic methods of use ➤ Sign Up
6,673,803 Quinazoline derivatives and pharmaceutical compositions containing them ➤ Sign Up
7,253,185 Amino ceramide-like compounds and therapeutic methods of use ➤ Sign Up
6,569,889 Amino ceramide-like compounds and therapeutic methods of use ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Genzyme Corp Drugs

Supplementary Protection Certificates for Genzyme Corp Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00738 Netherlands ➤ Sign Up PRODUCT NAME: ELIGLUSTAT, OF FYSIOLOGISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/14/974 20150119
2015000051 Germany ➤ Sign Up PRODUCT NAME: ELIGLUSTAT, GGF. IN FORM EINES PHYSIOLOGISCH ANNEHMBAREN SALZES; REGISTRATION NO/DATE: EU/1/14/974 20150119
2015 00035 Denmark ➤ Sign Up PRODUCT NAME: ELIGLUSTAT, EVENTUELT I FORM AF ET FYSIOLOGISK ACCEPTABELT SALT, HERUNDER ELIGLUSTAT (SOM TARTRAT); REG. NO/DATE: EU/1/14/974 20150119
90029-3 Sweden ➤ Sign Up PRODUCT NAME: ELIGLUSTAT, VALFRITT I FORM AV ETT FYSIOLOGISKT GODTAGBART SALT; REG. NO/DATE: EU/1/14/974 20150121
12/029 Ireland ➤ Sign Up PRODUCT NAME: VANDETANIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/11/749/001-002 20120217
15/027 Ireland ➤ Sign Up PRODUCT NAME: ELIGLUSTAT, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY ACCEPTABLE SALT; REGISTRATION NO/DATE: EU/1/14/974 20150119
717 Luxembourg ➤ Sign Up PRODUCT NAME: ELIGLUSTAT, EVENTUELLEMENT SOUS LA FORME D UN SEL PHYSIOLOGIQUEMENT ACCEPTABLE. FIRST REGISTRATION: 20150121
00543 Netherlands ➤ Sign Up PRODUCT NAME: VANDETANIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/11/749/001-002 20120217
0150027 00161 Estonia ➤ Sign Up PRODUCT NAME: ELIGLUSTAAT;REG NO/DATE: EU/1/14/974 21.01.2015
/2015 Austria ➤ Sign Up PRODUCT NAME: ELIGLUSTAT, OPTIONAL IN DER FORM EINES PHYSIOLOGISCH AKZEPTABLEN SALZES; REGISTRATION NO/DATE: EU/1/14/974 20150119
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Chinese Patent Office
US Army
Harvard Business School
McKesson
Moodys
Cantor Fitzgerald
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot